When accessed through vehicles with competitive fees, the T. Rowe Price Blue Chip Growth strategy remains one of the better choices in a deep Morningstar Category, thanks to the depth and breadth of its research effort and its capable portfolio manager.
T. Rowe Price Blue Chip Growth Fund TRBCX
- NAV / 1-Day Return 213.47 / −0.90 %
- Total Assets 65.6B
-
Adj. Expense Ratio
0.700%
- Expense Ratio 0.700%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 18%
USD | NAV as of Jun 17, 2026 | 1-Day Return as of Jun 17, 2026, 12:11 AM GMT+0
Morningstar’s Analysis TRBCX
Will TRBCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the TRBCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of TRBCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 67.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 15.20 | 10B | Technology |
Microsoft Corp | 9.50 | 6B | Technology |
Apple Inc | 8.89 | 6B | Technology |
Amazon.com Inc | 7.37 | 5B | Consumer Cyclical |
Alphabet Inc Class C | 6.78 | 4B | Communication Services |
Broadcom Inc | 6.03 | 4B | Technology |
Meta Platforms Inc Class A | 4.61 | 3B | Communication Services |
Carvana Co Class A | 3.86 | 3B | Consumer Cyclical |
Visa Inc Class A | 2.67 | 2B | Financial Services |
Eli Lilly and Co | 2.63 | 2B | Healthcare |
United States